A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Participants With an F508del CFTR Mutation
Clinical trial NCT03537651 · COMPLETED
Trial details
- NCT number
- NCT03537651
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2020-10-28
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.